1Eva-Maria Mandelkow,Eckhard Mandelkow.Tau in Alzheimer's disease[J].Trends in cell biology,1998,8:425-427.
2Price D.L.,Sisodia S.S.,Borchelt D.R.Genetic neurodegenerative disease:the human illness and transgenic models[J].Science,1998,282:1079-1083.
3JohnHardy,Dennis J.Selkoe.The Amyloid Hypothesis of Alzheimer's Disease:Progress and Problems on the Road to Therapeutics[J].Science,2002,297:353-357.
5Evgeni Kirazov,Ludmil Kirazov,Volker Biglet al.Ontogenetic changes in protein level of amyloid precursor protein in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embry[J].Int.J.Devl Neuroscience,2001,19:287-296.
6Alison Goate,Marie-Christine Chartier-Harlin,Mike Mullan et al.Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease[J].Nature,1991,349:704-706.
7Jillian R.A.Newton,David Parkinson,Malcolm R.Clench.Strategies for examination of Alzheimer's disease amyloid precursor protein isoforms[J].Anal Bioanal Chem,2006,385(4):692-699.
8Mok S S,Shema G,Heffeman D et al.Expression and analysis of heparin-binding region of amyloid precursor protein of Alzheimer's diseae[J].FEBS Lett,1997,415(3):303-307.
2Wirak DO, Bayney R, Rambhadran TV, et od. Deposits of amyloid beta protein in the central nervous system of transgenic mice [J].Science,1991,253 (5017) :323-325.
4Lamb BT, Call LM, Slum HH, et al. Altered metabolism of familial Alzheimer' s disease-liked amyloid precursor protein variants in yeast artificial chronmsome transgenic mice [ J ]. Hum Mol Genet, 1997,6(9) : 1535-1541.
5Dodart JC,Mathis C, Saura J, et od. Neuroanatomical abnormalities in behaviorally characterized APP( V717F) transgenic mice[J]. Neurobiol Dis, 2000,7(2) :71-85.
6Dodart JC, Meziane H, Mathis C, et al. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein[J]. Behav Neurosci, 1999,113(5) :982-990.
7Dodart JC, Mathis C, Bales KR, et al. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein[J]. Neurosci Lett, 1999,277( 1 ) : 49-52.
8Murphy GM, Zhao F, Yang L, et al. Expression of macrophage colonystimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease[J]. Am J Pathol,2000,157(3) : 895-904.
9Bales KR,Verina T, Cummins DJ, et o2. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer' s disease [ J ]. Proc Nail Acad Sci USA, 1999, 96 ( 26 ) :15233-15238.
10Holtzman DM, Fagan AM, Mackey B, et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer' s disease model[J] .Ann Neurol,2000,47(6) :739-747.
